WELL HEALTH TECHNOLOGIES COR (WELL.CA) Stock Fundamental Analysis
TSX:WELL - Toronto Stock Exchange - CA94947L1022 - Common Stock - Currency: CAD
Overall WELL gets a fundamental rating of 4 out of 10. We evaluated WELL against 17 industry peers in the Health Care Providers & Services industry. WELL has a medium profitability rating, but doesn't score so well on its financial health evaluation. WELL is not overvalued while it is showing excellent growth. This is an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year WELL was profitable.
In the past year WELL had a positive cash flow from operations.
In multiple years WELL reported negative net income over the last 5 years.
Of the past 5 years WELL 4 years had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 1.80%, WELL is doing good in the industry, outperforming 70.59% of the companies in the same industry.
WELL's Return On Equity of 3.76% is fine compared to the rest of the industry. WELL outperforms 70.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.8% | ||
| ROE | 3.76% | ||
| ROIC | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
WELL's Profit Margin of 3.55% is fine compared to the rest of the industry. WELL outperforms 70.59% of its industry peers.
WELL has a Gross Margin (39.47%) which is in line with its industry peers.
In the last couple of years the Gross Margin of WELL has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 3.55% | ||
| GM | 39.47% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
2. Health
2.1 Basic Checks
WELL does not have a ROIC to compare to the WACC, probably because it is not profitable.
WELL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for WELL has been increased compared to 5 years ago.
WELL has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.04, we must say that WELL is in the distress zone and has some risk of bankruptcy.
WELL has a Altman-Z score of 1.04. This is comparable to the rest of the industry: WELL outperforms 52.94% of its industry peers.
WELL has a Debt/Equity ratio of 0.51. This is a neutral value indicating WELL is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.51, WELL is doing good in the industry, outperforming 76.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.51 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.04 |
ROIC/WACCN/A
WACC7.15%
2.3 Liquidity
A Current Ratio of 0.91 indicates that WELL may have some problems paying its short term obligations.
WELL has a Current ratio of 0.91. This is in the better half of the industry: WELL outperforms 70.59% of its industry peers.
A Quick Ratio of 0.90 indicates that WELL may have some problems paying its short term obligations.
WELL has a better Quick ratio (0.90) than 70.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.91 | ||
| Quick Ratio | 0.9 |
3. Growth
3.1 Past
WELL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 183.33%, which is quite impressive.
The Revenue has grown by 18.51% in the past year. This is quite good.
The Revenue has been growing by 94.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)18.51%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%1.52%
3.2 Future
WELL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.85% yearly.
The Revenue is expected to grow by 13.73% on average over the next years. This is quite good.
EPS Next Y46.2%
EPS Next 2Y30.38%
EPS Next 3Y30.92%
EPS Next 5Y30.85%
Revenue Next Year40.4%
Revenue Next 2Y22.96%
Revenue Next 3Y17.8%
Revenue Next 5Y13.73%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
WELL is valuated quite expensively with a Price/Earnings ratio of 26.33.
76.47% of the companies in the same industry are more expensive than WELL, based on the Price/Earnings ratio.
WELL's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.22.
WELL is valuated rather expensively with a Price/Forward Earnings ratio of 18.01.
WELL's Price/Forward Earnings ratio is rather cheap when compared to the industry. WELL is cheaper than 88.24% of the companies in the same industry.
WELL is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 20.86, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.33 | ||
| Fwd PE | 18.01 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as WELL.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 32.33 |
4.3 Compensation for Growth
WELL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
WELL's earnings are expected to grow with 30.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.57
PEG (5Y)N/A
EPS Next 2Y30.38%
EPS Next 3Y30.92%
5. Dividend
5.1 Amount
No dividends for WELL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:WELL (5/2/2025, 7:00:00 PM)
3.95
-0.01 (-0.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners6.33%
Inst Owner ChangeN/A
Ins Owners8.41%
Ins Owner ChangeN/A
Market Cap998.99M
Analysts81
Price Target8.02 (103.04%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1770.58%
Min EPS beat(2)-3335.29%
Max EPS beat(2)-205.87%
EPS beat(4)2
Avg EPS beat(4)4485.92%
Min EPS beat(4)-3335.29%
Max EPS beat(4)21178.4%
EPS beat(8)2
Avg EPS beat(8)1637.02%
EPS beat(12)3
Avg EPS beat(12)1050.55%
EPS beat(16)3
Avg EPS beat(16)684.28%
Revenue beat(2)0
Avg Revenue beat(2)-6.49%
Min Revenue beat(2)-12.61%
Max Revenue beat(2)-0.37%
Revenue beat(4)1
Avg Revenue beat(4)-3.08%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)0.74%
Revenue beat(8)4
Avg Revenue beat(8)-0.64%
Revenue beat(12)7
Avg Revenue beat(12)0.43%
Revenue beat(16)11
Avg Revenue beat(16)1.37%
PT rev (1m)-9.38%
PT rev (3m)-7.11%
EPS NQ rev (1m)107.55%
EPS NQ rev (3m)66.04%
EPS NY rev (1m)36.27%
EPS NY rev (3m)102.35%
Revenue NQ rev (1m)3.51%
Revenue NQ rev (3m)8.53%
Revenue NY rev (1m)20.78%
Revenue NY rev (3m)22.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.33 | ||
| Fwd PE | 18.01 | ||
| P/S | 1.09 | ||
| P/FCF | N/A | ||
| P/OCF | 97.7 | ||
| P/B | 1.15 | ||
| P/tB | N/A | ||
| EV/EBITDA | 32.33 |
EPS(TTM)0.15
EY3.8%
EPS(NY)0.22
Fwd EY5.55%
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.04
OCFY1.02%
SpS3.64
BVpS3.43
TBVpS-1.07
PEG (NY)0.57
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.8% | ||
| ROE | 3.76% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 3.55% | ||
| GM | 39.47% | ||
| FCFM | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score4
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.51 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 10.71 | ||
| Cap/Depr | 22.44% | ||
| Cap/Sales | 1.76% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 24.61% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.91 | ||
| Quick Ratio | 0.9 | ||
| Altman-Z | 1.04 |
F-Score4
WACC7.15%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y46.2%
EPS Next 2Y30.38%
EPS Next 3Y30.92%
EPS Next 5Y30.85%
Revenue 1Y (TTM)18.51%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%1.52%
Revenue Next Year40.4%
Revenue Next 2Y22.96%
Revenue Next 3Y17.8%
Revenue Next 5Y13.73%
EBIT growth 1Y-189.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year202.45%
EBIT Next 3Y54.18%
EBIT Next 5Y44.13%
FCF growth 1Y-110.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.44%
OCF growth 3Y-22.85%
OCF growth 5YN/A